Maiwei (Shanghai) Biotechnology Co., Ltd
Initial public offering and listing on the science and Innovation Board
Appendix to prospectus
catalogue
1 issuance recommendation letter 2 legal opinion 3 lawyer work report 4 financial statements and audit report 5 articles of Association (Draft) 6 internal control assurance report 7 non recurring profit and loss statement verified by certified public accountants 8 documents approved by CSRC for the registration of the issuer’s public offering
Reply of China Securities Regulatory Commission on approval of registration of initial public offering of shares of Maiwei (Shanghai) Biotechnology Co., Ltd. (zjxk [2021) No. 3859)
Maiwei (Shanghai) Biotechnology Co., Ltd.:
China Securities Regulatory Commission has received the examination opinions on your company’s initial public offering and listing on the science and Innovation Board submitted by Shanghao stock exchange and your company’s registration application documents. According to the securities law of the people’s Republic of China, the company law of the people’s Republic of China, the notice of the general office of the State Council on the implementation of the revised Securities Law, the opinions on the implementation of the pilot registration system for the establishment of the science and innovation board in Shanghai stock exchange, and the measures for the administration of the registration of initial public offering of shares on the science and Innovation Board (for Trial Implementation) (order of CSRC No. 174) and other relevant provisions, after reviewing the review opinions of Shanghai Stock Exchange and your company’s registration application documents, the reply is as follows:
1、 Agree to your company’s application for registration of initial public offering.
2、 Your company shall strictly follow the prospectus and issuance and underwriting plan submitted to Shanghao stock exchange.
3、 This reply shall be valid for 12 months from the date of consent to registration.
4、 From the date of consent to registration to the end of this stock issue, if any major event occurs to your company, you shall timely report it to Shanghao stock exchange and deal with it in accordance with relevant regulations. CC: Shanghai Municipal People’s government; Shanghai Securities Regulatory Bureau, Shanghai Stock Exchange, China Securities Depository and Clearing Co., Ltd. and its Shanghai Branch, Haitong Securities Company Limited(600837) Co., Ltd.
Distribution: meeting leaders.
General office, Distribution Department, marketing department I, listing department, legal department, filing.
Printed and distributed by the general office of CSRC on December 7, 2021 typed by: Xu mengran proofread by: he Zhiyun printed 15 copies in total – 2-11111111 fried chips I
